Liquid-Based Cervical Cytology for Cervical Cancer Screening: A Retrospective Analysis of 61610 Cases

doi:10.3877/cma.j.issn.1673-5250.2012.01.006

Objective

To evaluate the value of liquid-based cytological test (LCT) as a screening method to detect cervical carcinoma.

Methods

The clinical data of 61 610 cases were collected from March 2004 to March 2011. The LCT results and colposcopic biopsy of 61 610 cases and 128 554 conventional Papnicoulau smears (CP) were compared and retrospectively analyzed. Follow-up diagnoses of colposcopic biopsy were available for those previously detected cytological abnormalities.

Results

① Among 61 610 LCT results, 1772 (2.88%) cases were cytological interpreted as atypical squamous cell of undetermined significance (ASCUS) or above, and among them, 1017 cases who received colposcopic biopsy showed 38 (0.06%, 38/61 610) were squamous cell carcinoma (SCC) or cervical adenocarcinoma (GLCA), 251 (0.41%, 284/61 610) were high grade squamous intraepithelial lesions (HSIL) [cervical intraepithelial neoplasia (CIN) Ⅱ, Ⅲ were 169 cases and 82 cases, respectively], 409 (0.66%, 399/61 610) were low grade squamous intraepithelial lesions (LSIL) (216 were condyloma and 193 were CIN I), atypical glandular cell (AGC) were 5 cases, adenocarcinomain situ (AIS) were 2 cases, and chronic inflammation were 312 cases. In the results of 128 554 specimen by CP, 272 cases (0.21%) were cytological interpreted as Pap Ⅲ or above. Among these 272 cases, 253 who received biopsy showed that 65 cases were cytological interpreted as SCC or GLCA, 97 were HSIL including 57 for CINⅡ and 40 for CINⅢ, 82 were LSIL including 45 for CINⅠ and 37 for condyloma, 9 were chronic inflammation. There was no significant difference between CP and LCT in detecting cervical carcinoma. ② The consistent rate of LCT and histological diagnosis was the follow: HSIL(82.77%, 173/209)>SCC(73.53%, 25/34)>LSIL(63.46%, 264/416).

Conclusions

Compared with CP, LCT has more sensitivity and reliability in screening for cervical carcinoma and SIL, especially in detecting HSIL. But we must pay more attention to the misdiagnosis or under-diagnosis of cervical carcinoma because of scant cellular, cell overlying, inflammation, etc. in the preparations.

Key words: cervical intraepithelial neoplasia, screening, liquid-based cytology test, the Bethesda System, pap smears, cervical cancer

表1 61 610例LCT标本的LCT初筛和复核结果比较[n(%)]

Table 1 Primary and re－review interpretation of 61 610 cases by liquid－based cytology test [n(%)]

TBS诊断结果		初筛率	复核后检出率
ASCUS		996(1.617)	749(1.220)
ASC－H		68(0.100)	36(0.060)
LSIL		780(1.279)	632(1.026)
?	HPV感染	280(0.454)	195(0.317)
?	CIN Ⅰ	354(0.575)	297(0.482)
?	CIN Ⅰ合并HPV	155(0.252)	140(0.227)
HSIL		269(0.437)	237(0.385)
?	CIN Ⅱ	180(0.292)	164(0.266)
?	CIN Ⅲ	54(0.087)	40(0.065)
?	HSIL合并HPV	35(0.057)	33(0.054)
AGC－NOS		75(0.122)	48(0.078)
AGC－倾向肿瘤		31(0.050)	29(0.047)
AIS		2(0.003)	2(0.003)
SCC		29(0.047)	37(0.060)
腺癌		1(0.002)	2(0.003)
合计		2250(3.652)	1772(2.876)

表1 61 610例LCT标本的LCT初筛和复核结果比较[n(%)]

Table 1 Primary and re－review interpretation of 61 610 cases by liquid－based cytology test [n(%)]

TBS诊断结果		初筛率	复核后检出率
ASCUS		996(1.617)	749(1.220)
ASC－H		68(0.100)	36(0.060)
LSIL		780(1.279)	632(1.026)
?	HPV感染	280(0.454)	195(0.317)
?	CIN Ⅰ	354(0.575)	297(0.482)
?	CIN Ⅰ合并HPV	155(0.252)	140(0.227)
HSIL		269(0.437)	237(0.385)
?	CIN Ⅱ	180(0.292)	164(0.266)
?	CIN Ⅲ	54(0.087)	40(0.065)
?	HSIL合并HPV	35(0.057)	33(0.054)
AGC－NOS		75(0.122)	48(0.078)
AGC－倾向肿瘤		31(0.050)	29(0.047)
AIS		2(0.003)	2(0.003)
SCC		29(0.047)	37(0.060)
腺癌		1(0.002)	2(0.003)
合计		2250(3.652)	1772(2.876)

表2 1017例细胞学结果呈阳性患者的多点组织活检诊断结果

Table 2 Interpretation of cytology versus reference standard (histology diagnosis)

TBS诊断结果	多点组织活检诊断
TBS诊断结果	Negative	湿疣	CIN Ⅰ	CINⅡ	CIN Ⅲ	SCC	AGC	AIS	GLCA	总计
ASCUS	148	58	39	11	1	0	0	0	0	257
ASC－H	10	1	3	11	7	2	0	0	2	36
湿疣	37	45	9	4	0	0	0	0	0	95
CIN Ⅰ	54	45	52	6	0	0	0	0	0	157
CIN Ⅰ合并湿疣	36	56	57	13	2	0	0	0	0	164
CIN Ⅱ	3	7	18	82	21	1	0	0	0	132
CIN Ⅲ	0	1	1	24	32	2	0	0	0	60
HSIL合并湿疣	0	1	1	9	5	1	0	0	0	17
SCC	0	0	0	2	10	25	0	0	0	37
AGC－NOS	18	1	13	4	0	0	4	0	0	40
AGC－倾向肿瘤	6	1	0	3	3	2	1	1	1	18
AIS	0	0	0	0	0	1	0	1	0	2
腺癌	0	0	0	0	1	0	0	0	1	2
合计	312	216	193	169	82	34	5	2	4	1017

表2 1017例细胞学结果呈阳性患者的多点组织活检诊断结果

Table 2 Interpretation of cytology versus reference standard (histology diagnosis)

TBS诊断结果	多点组织活检诊断
TBS诊断结果	Negative	湿疣	CIN Ⅰ	CINⅡ	CIN Ⅲ	SCC	AGC	AIS	GLCA	总计
ASCUS	148	58	39	11	1	0	0	0	0	257
ASC－H	10	1	3	11	7	2	0	0	2	36
湿疣	37	45	9	4	0	0	0	0	0	95
CIN Ⅰ	54	45	52	6	0	0	0	0	0	157
CIN Ⅰ合并湿疣	36	56	57	13	2	0	0	0	0	164
CIN Ⅱ	3	7	18	82	21	1	0	0	0	132
CIN Ⅲ	0	1	1	24	32	2	0	0	0	60
HSIL合并湿疣	0	1	1	9	5	1	0	0	0	17
SCC	0	0	0	2	10	25	0	0	0	37
AGC－NOS	18	1	13	4	0	0	4	0	0	40
AGC－倾向肿瘤	6	1	0	3	3	2	1	1	1	18
AIS	0	0	0	0	0	1	0	1	0	2
腺癌	0	0	0	0	1	0	0	0	1	2
合计	312	216	193	169	82	34	5	2	4	1017

表3 巴氏涂片诊断与多点组织活检结果对照

Table 3 Interpretation of conventional Pap smears versus reference standard (histology diagnosis)

巴氏分级	多点组织活检
巴氏分级	Negative	HPV	CIN Ⅰ	CINⅡ	CIN Ⅲ	SCC	GLCA	总计
巴氏Ⅲ级	9	37	42	27	44	39	0	198
巴氏Ⅳ级	0	0	3	12	12	15	0	42
巴氏Ⅴ级	0	0	0	1	1	9	0	11
GLCA	0	0	0	0	0	0	2	2
合计	9	37	45	40	57	63	2	253

表3 巴氏涂片诊断与多点组织活检结果对照

Table 3 Interpretation of conventional Pap smears versus reference standard (histology diagnosis)

巴氏分级	多点组织活检
巴氏分级	Negative	HPV	CIN Ⅰ	CINⅡ	CIN Ⅲ	SCC	GLCA	总计
巴氏Ⅲ级	9	37	42	27	44	39	0	198
巴氏Ⅳ级	0	0	3	12	12	15	0	42
巴氏Ⅴ级	0	0	0	1	1	9	0	11
GLCA	0	0	0	0	0	0	2	2
合计	9	37	45	40	57	63	2	253

表4 两种方法检出鳞状上皮细胞内病变、鳞状上皮细胞癌及其组织学诊断的比较

Table 4 Detection of squamous intraepithelial lesion and squamous cell carcinoma by both cytological techniques versus reference standard (histology diagnosis)

方法	n	细胞学结果呈阳性	活检数	组织学结果
方法	n	细胞学结果呈阳性	活检数	HSIL	LSIL	SCC＋GLCA
LCT	61 610	1772	1017	257	408	38
巴氏涂片	128 554	272	253	97	82	65

表4 两种方法检出鳞状上皮细胞内病变、鳞状上皮细胞癌及其组织学诊断的比较

Table 4 Detection of squamous intraepithelial lesion and squamous cell carcinoma by both cytological techniques versus reference standard (histology diagnosis)

方法	n	细胞学结果呈阳性	活检数	组织学结果
方法	n	细胞学结果呈阳性	活检数	HSIL	LSIL	SCC＋GLCA
LCT	61 610	1772	1017	257	408	38
巴氏涂片	128 554	272	253	97	82	65

图4B 左图的组织学对照宫颈小细胞非角化性鳞癌 (HE×100)

Figure 4B Follow up histology was invasive nonkeratinized small－sized squamous carcinoma of the cervix. (HE ×100)

图5B 左图的组织学对照宫颈小细胞非角化性鳞癌 (HE×100)

Figure 5B Follow up histology of the patient of the left figure was invasive nonkeratinized small－sized squamous carcinoma of the cervix. (HE ×100)

图1B 左图的组织学对照宫颈腺癌，病变较表浅，本例局灶原位腺癌 (HE×100)

Figure 1B Follow up histology the patient of the left figure was cervical superficial adenocarcinoma with foci AIS. (HE ×100)

图2B 左图的组织学对照(HE×100) 宫颈原位腺癌

Figure 2B Follow up histology of the patient of the left figure was AIS. (HE ×100)

图3B 左图的组织学对照，宫颈黏液腺癌(HE×400)

Figure 3B Follow up histology of the patient of the left figure was invasive endocervical adenocarcinoma. (HE ×100)

1	Lang JH. Diagnosis and treatment of cervical intraepithelial neoplasia [J]. Chin J Obstet Gynecol, 2000, 36(5):261-263.
2	Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology [J]. JAMA, 2002, 287(16):2114-2119.
3	Weintraub J, Morabia A. Efficacy of a liquid－based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer [J]. Diagn Cytopathol, 2000, 22(1):52-59.
4	Carpenter AB, Davey DD. ThinPrep Pap Test: Performance and biopsy follow－up in a university hospital [J]. Cancer, 1999, 87(3):105-112.
5	Cheung AN, Szeto EF, Leung BS, et al. Liquid－based cytology and conventional cervical smears: A comparison study in an Asian screening population [J]. Cancer, 2003, 99(6):331-335.
6	Pan QJ, Li L, Zhang X, et al. Study on liquid－based cytology for cervical carcinoma screening in a high－risk area of China [J]. Chin J Oncol, 2001, 23(4):50-53.
7	Wang SZ, Sun JH. Examination and prognosis of cervical intraepithelial lesions [J]. Chin J Obstet Gynecol, 1999, 34(12):754-756.
8	Diane S, Ritu N. The Bethesda system for reporting cervical cytology: Definitions, criteria, and explanatory notes. 2nd ed [M]. New York: Springer, 2004.
9	Wu D, Ding L, Wu JH, et al. Application of liquid－based cytology and high－risk human papillomavirus DNA detection in cervical lesion screening [J]. J Southern Med Univ, 2007, 27(9):1421-1423.
10	Limaye A, Connor AJ, Huang X, et al. Comparative analysis of conventional Papanicolaou tests and a fluid－based thin－layer method [J]. Arch Pathol Lab Med, 2003, 127(2):200-204.
11	Quddus MR, Sung CJ, Steinhoff MM, et al. Atypical squamous metaplastic cells: Reproducibility, outcome, and diagnostic features on ThinPrep Pap test [J]. Cancer, 2001, 93(1):16-22.
12	Liu S, Semenciw R, Probert A, et al. Cervical cancer in Canada: Changing patterns in incidence and mortality [J]. Int J Gynecol Cancer, 2001, 11(1):24-31.
13	Prasad CJ, Sheets E, Selig AM, et al. The binucleate squamous cell: Histologic spectrum and relationship to low－grade squamous intraepithelial lesions [J]. Mod Pathol, 1993, 6(3):313-317.

[1]	Jiu Wang, Jun Chen, Xia Zhu, Yangjin Mima, Sheng Zhao, Xinlin Chen, Jianhua Li, Shuang Wang. Effect of implementing fetal systemic ultrasound screening in Material and Child Health Hospital of Shannan[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(07): 728-733.
[2]	Ling Wei, Hui Li, Yi Chen. Current research status on colonization or infection and mother-to-child transmission of extended-spectrum β-lactamase-producing Enterobacteriaceae in pregnant and post-partum women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 517-521.
[3]	Haolin Zhang, Xu Zhang, Kun Liang, Zuolin Jin, Jie Gao. Advances in diagnosis and screening of adenoid hypertrophy in children[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2023, 17(02): 123-127.
[4]	Yanqing Gao, Fei Han, Huaijun Zhu, Peng Song, Liang Tao, Wenxian Guan, Xiaojie Bian. Applicability of nutritional risk screening and assessment in patients undergoing surgery for gastric cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(02): 167-171.
[5]	Xiaojuan Li, Weijia Li, Lingyan Peng, Pengying Zhou, Gui'e Li, Xiangchen Liu. Analysis of the clinical characters of prostate calcification in physical examination population[J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(04): 336-338.
[6]	Kai Yan, Yong Fu, Zhengtao Zhang. Predictive model of therapeutic effect of middle and advanced liver cancer and research progress of organoid models of liver cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 348-351.
[7]	Hongzhi Liu, Jingfeng Liu. Application of big data and artificial intelligence in screening and diagnosis of primary liver cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(01): 1-5.
[8]	Wenqi Sun, Xinrong Wu, Yunrong Wang, Bei Zhao, Xiaotan Dou, Wen Li, Xiaoping Zou, Lei Wang, Min Chen. The value of measuring ROS and FH in colorectal epithelial cells for colorectal cancer screening[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(04): 326-330.
[9]	Yimin E, Sizheng Sun, Xiaoyu Fan, Chunzhao Yu. Present status and prospect of fecal screening for colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(04): 331-336.
[10]	Qian Liu, Wei Cui, Yibo Gao, Zeyue Zhang, Diange Li, Zhijie Wang, Jie Wang, Jie He, Expert Group of China Guideline for the Screening and Early Diagnosis and Treatment of Colorectal Cancer. New screening strategies for early colorectal tumors: a screening protocol based on liquid biopsy techniques[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(01): 17-20.
[11]	Jingke Li, Yanchun Zhang, Jiayi Wu, Xiuyu Ren. Deep learning for diabetic retinopathy screening, classification and management[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2023, 13(04): 241-246.
[12]	Chenxi Zong, Lin Xiao, Hongxin Song. Advances and prospects in the application of artificial intelligence vision screening in the prevention and control of myopia[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2023, 13(01): 60-64.
[13]	Hang Xu, Yutao Cui, Guangkai Ren, He Liu, Yanbing Wang, Chuangang Peng, Dankai Wu. Screening and Bioinformatics Analysis of Core Genes of Osteoporosis[J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(01): 18-22.
[14]	Xin Jiang, Chun Pan, Wenhui Huang, Guifen Gan. A study on active CRE screening and CRE infection in anal swabs in Intensive Care Units in Qinghai area[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(02): 178-184.
[15]	Mi Li, huajuan Qiu, Yanqin Ji, Minghui Zhou. Effect of P16 and Ki67 expression and viral load detection on outcome of cervical lesions in woman of childbearing age with cervical intraepithelial neoplasia grade Ⅱ complicated with high-risk human papillomavirus infection[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(03): 272-278.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export